['stress urinary incontinence']
['gtx 024', 'placebo']

        Key Inclusion Criteria:

          -  SUI symptoms of at least 6 months duration

          -  Predominant SUI as determined at the Screening Visit using the Medical,
             Epidemiological, and Social Aspects of Aging (MESA) urinary questionnaire.

          -  24-Hour pad weight > 3 g during the screening period

          -  A minimum of 1 and no more than 15 SUI episodes on any single day AND no fewer than 9
             total SUI episodes over 3 days during the screening period

          -  Positive bladder stress test conducted during the Screening Visit

        Key Exclusion Criteria:

          -  History of pelvic radiation treatment

          -  History of urethral diverticula

          -  History of urethral sling or anterior prolapse repair

          -  Treatment with urethral bulking agents and/or other SUI procedure or surgery within
             the 6 months prior to the Screening Visit

          -  Known vesicoureteral reflux, vaginal prolapse beyond the introitus, or other
             significant pelvic floor abnormalities

          -  Urinary incontinence of neurogenic etiology

          -  Morbidly obese (defined as 100 pounds over ideal body weight, or body mass index 40 or
             greater)

          -  Chronic hepatitis

          -  Hepatic cirrhosis

          -  Evidence of active infection with hepatitis B or hepatitis C

          -  History of human immunodeficiency virus (HIV) infection

          -  Subjects with a history of breast or endometrial cancer
      